Transition your customer engagement strategies to better meet the evolving needs of physicians and patients and drive more effective and productive interactions in the evolving healthcare landscape.
Driving your brand performance amidst budget cuts to reach an overwhelmed customer base requires a fresh look at the way you go to market. Are you evolving the role that MSLs, sales reps, omnichannel engagement and patient support programmes play to meet the needs of HCP and patients when and how they want?
Inizio Engage commissioned an independent market research report looking to understand what the future of HCP and patient engagement will look like, engaging 22 global Pharma leaders situated in Europe from a total of 12 pharmaceutical companies.
We then shared these insights with workshop attendees at industry conferences and gained real-time feedback on the investment and progress of this transformation.
While you’ll be very familiar with the trends dominating conversations, we believe it’s critical to continue interrogating where organizations really are on the customer engagement transformation journey.
84% of pharma leaders surveyed identified investment in non-promotional, MSL-led scientific engagement is ‘critical’ or ‘very important’.
58% of EU, 69% of US leaders surveyed are transforming the role of the sales rep to develop more scientifically informed partnerships with HCPs.
“If I had to hire someone, I need someone that has good communication, interpersonal skills. I mean, that’s MSL 101. I think they need to be strategic, more business minded than they are now.”
“Rather than trying to take reps that have been doing it face-to-face for the last 20 years, who are quite happy doing it that way. I think the easiest bridge to the future is to create a new entirely digital role.”
For more market research and survey data, download our report here:
